Michael J Herron
Overview
Explore the profile of Michael J Herron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Herron M, Ericson M, Kurtti T, Munderloh U
Ann N Y Acad Sci
. 2006 Feb;
1063:374-82.
PMID: 16481545
Ixodes scapularis ticks transmit Anaplasma phagocytophilum (Ap), agent of human granulocytic anaplasmosis (HGA). Invasion of neutrophil granulocytes (PMN) by Ap is the hallmark of the disease, but these short-lived phagocytes...
12.
Wacnik P, Baker C, Herron M, Kren B, Blazar B, Wilcox G, et al.
Pain
. 2005 Apr;
115(1-2):95-106.
PMID: 15836973
Functional and anatomical relationships among primary afferent fibers, blood vessels, and cancers are poorly understood. However, recent evidence suggests that physical and biochemical interactions between these peripheral components are important...
13.
Baldridge G, Burkhardt N, Herron M, Kurtti T, Munderloh U
Appl Environ Microbiol
. 2005 Apr;
71(4):2095-105.
PMID: 15812043
We developed and applied transposon-based transformation vectors for molecular manipulation and analysis of spotted fever group rickettsiae, which are obligate intracellular bacteria that infect ticks and, in some cases, mammals....
14.
Munderloh U, Lynch M, Herron M, Palmer A, Kurtti T, Nelson R, et al.
Vet Microbiol
. 2004 Jun;
101(1):53-64.
PMID: 15201033
Anaplasma marginale and A. phagocytophilum are obligate intracellular, tick-borne pathogens that target erythrocytes and neutrophil granulocytes, respectively. Because ticks do not directly tap blood vessels, an intermediate tissue may mediate...
15.
Sauer M, Ericson M, Weigel B, Herron M, Panoskaltsis-Mortari A, Kren B, et al.
Cancer Res
. 2004 Jun;
64(11):3914-21.
PMID: 15173002
To determine the mechanisms by which adoptive immunotherapy could reduce lethality to acute myelogenous leukemia (AML), a novel technique was developed to track both leukemic blasts and adoptively transferred cytotoxic...